本文来自信达证券研发中心2025年11月11日发布的《维立志博研发日跟踪点评:崭露头角,蓄势待发》,欲了解具体内容,请阅读报告原文,唐爱金S1500523080002,赵丹S1500524120002。事件:维立志博2025年11月9日研发日更新多个产品研发进展点评:大样本临床数据表明:LBL-024彻底解决4-1B乙肝毒性问题。LBL-024(PD-L1/4-1BB双抗)单药或联合治疗在EP-...
Source Link本文来自信达证券研发中心2025年11月11日发布的《维立志博研发日跟踪点评:崭露头角,蓄势待发》,欲了解具体内容,请阅读报告原文,唐爱金S1500523080002,赵丹S1500524120002。事件:维立志博2025年11月9日研发日更新多个产品研发进展点评:大样本临床数据表明:LBL-024彻底解决4-1B乙肝毒性问题。LBL-024(PD-L1/4-1BB双抗)单药或联合治疗在EP-...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.